HIV and erectile dysfunction affect a meaningful number of South African men, given that an estimated 8 million South Africans, around 12.7% of the population, are living with HIV. This is a common, medically explainable combination of factors, not something to feel isolated about, and there’s a genuinely constructive path forward. Here are six essential facts.
1. ED Is Genuinely Common Among Men Living With HIV
Studies using validated assessment tools have found ED prevalence around 37.5% among men living with HIV on antiretroviral therapy, according to research published in Translational Andrology and Urology. Reported figures vary widely across different studies, from under 10% to over 70%, largely due to differences in how studies measure and define ED, but the consistent finding across the research is that this is a common, well-recognised issue, not a rare complication.
2. Several Factors Contribute, Not Just One
HIV and its treatment can affect erectile function through more than one pathway: metabolic changes affecting blood vessel health, psychological factors including depression, which research shows is notably common among people living with HIV in Southern Africa specifically, and, in some cases, effects related to specific antiretroviral regimens. This overlapping picture is similar to several other causes covered throughout this site, rarely just one thing acting alone.
3. Antiretroviral Therapy’s Direct Role Is Genuinely Unclear
Whether ART itself directly causes ED is an area with honestly contradicting research findings, some studies implicate certain regimens, including some integrase inhibitor-based treatments in African cohort studies, while others find no clear direct link. What’s more consistently documented is that ART is associated with changes in cholesterol levels, one South African cohort found dyslipidemia in the large majority of patients on treatment, which connects to the same vascular mechanisms covered in our cholesterol and erectile dysfunction guide.
This matters more than anything else on this page: never stop or change your antiretroviral therapy because of erectile dysfunction, or for any reason, without speaking to your treating doctor first. Interrupting ART carries serious health risks, including for your own long-term health and for onward transmission. If you suspect a specific medication is contributing to your ED, raise it with your doctor, there are often alternative regimens available, but this decision needs to be made together with the professional managing your HIV care.
4. Depression Is a Common, Treatable Contributing Factor
Research across Southern Africa has found depression notably common among people living with HIV on treatment, and depression is independently linked to erectile dysfunction, as covered in our psychological causes guide. This is worth taking seriously on its own terms, addressing mental health isn’t a side note here, it’s directly relevant to the physical symptom too.
5. Metabolic Monitoring Is Part of a Proper Assessment
Given the documented link between ART and cholesterol changes, a proper ED assessment for a man living with HIV reasonably includes the same lipid and metabolic screening covered in our assessment and testing guide, alongside a discussion of your specific ART regimen and any mood-related symptoms.
6. This Is Addressable, Openly and Without Judgement
Being open about your HIV status and treatment with whoever is assessing your ED gives them the full picture needed to help properly, in exactly the same way any other medical history matters. There’s nothing unusual or shameful about this combination of factors, it’s common, well-documented, and worth addressing directly rather than in silence.
A Private Self-Check
A few questions worth reflecting on:
2. Have you noticed low mood, or symptoms of depression, alongside your erectile changes?
3. Did your ED begin or change around when you started or switched an ART regimen?
4. Have you discussed sexual side effects openly with your treating doctor?
5. Have you been managing this alone rather than raising it with anyone?
Not a diagnosis, just a way to think through your own situation before a consultation. This is a common, addressable combination of factors.
Frequently Asked Questions | HIV and Erectile Dysfunction
Should I stop my ART if I think it’s causing my ED?
No, never stop or change antiretroviral therapy without speaking to your treating doctor first. If a specific medication seems related, your doctor can discuss whether an alternative regimen makes sense.
Is ED a sign my HIV isn’t well controlled?
Not necessarily, ED in men living with HIV is usually linked to a combination of metabolic, psychological and treatment-related factors, rather than being a direct marker of viral control on its own.
Can this practice help alongside my HIV treatment?
Yes, naturopathic support focused on lifestyle, nutrition and general wellbeing can reasonably sit alongside your HIV care, working with your treating doctor rather than instead of them.
Is it safe to take PDE5 inhibitors while on ART?
This needs to be checked specifically with your doctor or pharmacist, since some ART medications can interact with PDE5 inhibitors, this isn’t something to decide without that input.
Do I need to disclose my HIV status to get help for ED?
It genuinely helps whoever is assessing you to have the full picture, and this is treated as routine, confidential medical information, the same as any other health history.
Will my ED improve if I address the other contributing factors?
Often, yes, particularly where cholesterol, mood, or specific medication effects are addressed properly, meaningful improvement is realistic for many men.
Reviewed by George Mulaudzi, Naturopath, Erectile Dysfunction Clinic. This article provides general educational information and is not a substitute for personalised medical advice, diagnosis or emergency care. This practice does not manage HIV treatment; all HIV care and any changes to antiretroviral therapy must go through your treating doctor. Never stop or change antiretroviral therapy without medical guidance.
Comments are closed